奧拉帕尼是FDA批準(zhǔn)的癌癥靶向治療，它是PARP抑制劑，抑制多聚ADP核糖聚合酶（PARP），一種參與DNA修復(fù)的酶。它對(duì)遺傳性BRCA1或BRCA2突變的人群中的癌癥有效，包括某些卵巢癌、乳腺癌和前列腺癌。
tert-Butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazine-1-carboxylate
tert-Butyl piperazine-1-carboxylate
2-Fluoro-5-formylbenzonitrile
4-(4-Fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile
4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one
Cyclopropanecarboxylic acid chloride
2-Fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl)benzonitrile
Dimethyl (3-oxo-1,3-dihydroisobenzofuran-1-yl)phosphonate
3-Hydroxyisobenzofuran-1(3H)-one
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid
1-(Cyclopropylcarbonyl)piperazine hydrochloride
